INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 109 filers reported holding INTERSECT ENT INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,146,000 | -62.1% | 67,390 | -49.3% | 2.11% | -38.9% |
Q2 2019 | $3,025,000 | -41.6% | 132,924 | -17.5% | 3.45% | -17.8% |
Q1 2019 | $5,180,000 | +13.7% | 161,108 | -0.3% | 4.19% | -5.7% |
Q4 2018 | $4,554,000 | -15.1% | 161,587 | -13.4% | 4.44% | -1.6% |
Q3 2018 | $5,364,000 | -25.2% | 186,561 | -2.5% | 4.51% | -32.9% |
Q2 2018 | $7,167,000 | -7.3% | 191,382 | -2.7% | 6.72% | -14.5% |
Q1 2018 | $7,733,000 | +18.2% | 196,776 | -2.6% | 7.86% | +20.0% |
Q4 2017 | $6,543,000 | -6.4% | 201,943 | -10.0% | 6.55% | +2.3% |
Q3 2017 | $6,989,000 | -17.2% | 224,372 | -25.7% | 6.40% | -15.2% |
Q2 2017 | $8,440,000 | +39.3% | 301,963 | -14.5% | 7.56% | +27.6% |
Q1 2017 | $6,058,000 | +39.9% | 353,251 | -1.3% | 5.92% | +29.5% |
Q4 2016 | $4,329,000 | +14.5% | 357,795 | +49.9% | 4.57% | +22.3% |
Q3 2016 | $3,781,000 | -54.7% | 238,698 | -63.0% | 3.74% | -15.8% |
Q2 2016 | $8,341,000 | -10.2% | 645,078 | +32.0% | 4.44% | -12.4% |
Q1 2016 | $9,284,000 | -26.1% | 488,643 | -12.5% | 5.06% | -18.0% |
Q4 2015 | $12,563,000 | +22.4% | 558,339 | +27.2% | 6.18% | +11.8% |
Q3 2015 | $10,268,000 | -14.2% | 438,809 | +5.0% | 5.52% | +3.7% |
Q2 2015 | $11,961,000 | +461.8% | 417,788 | +406.8% | 5.33% | +465.5% |
Q1 2015 | $2,129,000 | – | 82,437 | – | 0.94% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|